Nathalie Strub Wourgaft
Dr Nathalie Strub Wourgaft joined DNDi as Clinical Development Director in February 2009. Dr Strub, who most recently served as Director, Clinical Development at Trophos, has over 15 years of clinical development experience, including with Pfizer from 2000 to 2003, and Lundbeck from 1995 to 1999. She also served as Medical Director for a CRO from 2004 to 2005 as well as for the French office of Aspreva from 2005 to 2008. Dr Strub graduated as Medical Doctor from Necker Hospital, University of Rene Descartes in Paris in 1983.